Are you optimally prepared to bring your innovative product from bench to clinic to market?

Register for our Product Development Plan workshop

Batavia Biosciences - Favicon

Join us at the BIO Convention for our exclusive workshop designed specifically for biotech companies to understand  your road to market.

During the workshop, we will share our expertise and industry knowledge in the development of a detailed product development plan which is pivotal to help you navigate the complexities of drug development and accelerate your path to market.

In this hands-on workshop, you will:

  • Gain a deeper understanding of the drug development process
  • Explore general challenges encountered when moving a product from bench to market
  • Understand the contents of a PDP
  • Next steps in successfully preparing your PDP

Don’t miss this unique opportunity to elevate your drug development strategy and bring your innovative therapies to patients quicker.

Date: Tuesday, June 6 from 7:30-10:30AM


Constitution Room
Seaport Hotel
1 Seaport Lane, Boston, MA 02210

Reserve your seat! Please note that it is free to register until 1 june 2023. After that date, a registration fee of $99.95  applies.

Secure your spot nowand unlock the full potential of your drug development journey.

Menzo Havenga, CEO

Menzo Havenga, CEO

Dr Menzo Havenga is a molecular virologist  with over 200 publications in international peer-reviewed scientific journals and inventor of more than 45 patents.

Menzo has worked at a variety of institutions including big pharma, biotech companies, and non-for-profit  organizations in C-suite leadership positions.

He has gained a wealth of experience in assessing businesss plans and product development plans and bringing products from early discovery to the market.

In 2010, after a successful career as head of R&D at Crucell, he launched his own company, Batavia Biosciences,  with Headquarters in the Netherlands and subsidiaries in the US and Asia. Since incoporation, he assumes the role as president and CEO of Batavia Group companies.

Low-cost viral vector manufacturing

High-throughput screening for viral vectors

Viral vector manufacturing

Thermostable viral envelope protein formulation

Maximizing protein expression